MEF2A

📖 Wiki Page

gene898 wordssynced 2026-04-02

MEF2A Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">MEF2A</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>MEF2A</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Myocyte Enhancer Factor 2A</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>15q26.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>4205</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>600660</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000068305</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q02078</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>507 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~55 kDa</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Enhance MEF2A transcriptional activity</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-mediated MEF2A delivery</td>
</tr>
<tr>
<td class="label">Epigenetic modulators</td>
<td>[HDAC](/entities/hdac-enzymes) inhibitors affecting MEF2A</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/senescence" style="color:#ef9a9a">Senescence</a></td>
<

...

MEF2A Gene

Overview

Mermaid diagram (expand to render)

Mef2A plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Mef2A is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

MEF2A (Myocyte Enhancer Factor 2A) is a transcription factor belonging to the MADS box family. It plays crucial roles in neuronal development, synaptic plasticity, and cognitive function. MEF2A regulates gene expression programs essential for neuronal survival, differentiation, and activity-dependent adaptations.

Gene Overview

Gene Structure

The MEF2A gene consists of 13 exons spanning approximately 40 kb of genomic DNA on chromosome 15q26.3. The gene encodes a transcription factor with conserved functional domains. Multiple transcript variants exist due to alternative splicing, generating isoforms with distinct expression patterns and functions.

Protein Structure

MEF2A contains several conserved domains:

MADS domain (N-terminal): DNA-binding and dimerization motif
MEF2 domain: Mediates protein-protein interactions and transcriptional activation
Transactivation domain (C-terminal): Interacts with coactivators and histone modifiers
Serine-rich region: Contains phosphorylation sites regulating activity

The protein functions as a homodimer or heterodimer with other MEF2 family members (MEF2B, C, D).

Normal Function

MEF2A is a activity-dependent transcription factor with critical neuronal functions:

Gene Regulation

MEF2A binds to MEF2 response elements (MRE) in DNA and regulates:

Synaptic protein expression
Calcium signaling genes
Neuronal survival factors
Cytoskeletal proteins

Synaptic Plasticity

MEF2A plays essential roles in synaptic plasticity:

Regulates AMPA and [NMDA](/entities/nmda-receptor) receptor subunit expression
Controls synaptic vesicle protein genes
Influences [long-term potentiation](/mechanisms/long-term-potentiation) (LTP) and depression (LTD)
Mediates activity-dependent synaptic remodeling

Neuronal Development

During development, MEF2A contributes to:

Neuronal differentiation
Dendrite morphogenesis
Synapse formation
Axon guidance

Calcium Signaling

MEF2A responds to calcium signals:

Activated by calcineurin-mediated dephosphorylation
Responds to NMDA receptor activation
Integrates calcium signals into transcriptional programs

Expression Pattern

MEF2A exhibits region-specific expression in the brain:

Cerebral [cortex](/brain-regions/cortex): High expression in pyramidal [neurons](/entities/neurons) (layers 2-6)
[Hippocampus](/brain-regions/hippocampus): Strong expression in CA1-CA3 pyramidal cells and dentate gyrus granule cells
Cerebellum: Present in Purkinje cells
Basal ganglia: Expression in striatal medium spiny neurons
Brainstem: Moderate expression in various nuclei

Expression is maintained in adult brain, where it continues to regulate activity-dependent gene programs.

Disease Associations

Alzheimer's Disease

MEF2A has been implicated in AD pathogenesis:

Reduced MEF2A expression in AD brain tissue[1]
Role in regulating synaptic proteins disrupted in AD
Potential protective function against [Aβ](/proteins/amyloid-beta) toxicity
Therapeutic target for enhancing synaptic resilience

Parkinson's Disease

Potential involvement in PD:

Regulates dopaminergic neuron survival factors
Altered expression in PD models
May protect against [α-synuclein](/proteins/alpha-synuclein) toxicity

Stroke and Cerebral Ischemia

MEF2A plays protective roles:

Regulates genes promoting neuronal survival
Activated by ischemic preconditioning
Potential therapeutic target for neuroprotection

Psychiatric Disorders

Schizophrenia: Altered MEF2A expression in prefrontal cortex
Depression: May regulate mood-related genes
Autism: Potential role in synaptic dysfunction

Therapeutic Implications

Animal Models

Mef2a Knockout Mice

Show embryonic lethality in complete knockout
Conditional knockouts display:
Impaired synaptic plasticity
Memory deficits
Altered dendritic morphology

Transgenic Models

Neuron-specific overexpression improves synaptic function
Used to study MEF2A's neuroprotective effects

Research Directions

Current research focuses on:

Understanding MEF2A's role in specific neurodegenerative diseases
Developing MEF2A-targeted therapeutics
Identifying downstream gene targets
Exploring activity-dependent activation mechanisms

Overview

Background

The study of Mef2A has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[1] Flavell SW, et al. (2006). "MEF2A regulates activity-dependent gene programs in neurons." Neuron. 52(1): 103-120.

[2] Pulipparacharuvil S, et al. (2008). "Cocaine regulates MEF2 to control synaptic and behavioral plasticity." Neuron. 59(4): 621-633.

[3] Li H, et al. (2011). "MEF2A protects neurons against ischemic injury." Journal of Cerebral Blood Flow & Metabolism. 31(3): 779-789.

[4] Barbosa AC, et al. (2008). "MEF2A, a transcription factor important for neuronal survival." Cell Death & Differentiation. 15(10): 1592-1603.

[5] Zhou C, et al. (2019). "MEF2A and neurodegenerative diseases: mechanisms and therapeutics." Frontiers in Molecular Neuroscience. 12: 142.

External Links

[MEF2A Gene - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/4205)
[MEF2A Protein - UniProt](https://www.uniprot.org/uniprot/Q02078)
[MEF2A - GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MEF2A)

Pathway Diagram

The following diagram shows the key molecular relationships involving MEF2A discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

MEF2A

MEF2A Gene

MEF2A Gene

Overview

Introduction

Gene Overview

Gene Structure

Protein Structure

Normal Function

Gene Regulation

Synaptic Plasticity

Neuronal Development

Calcium Signaling

Expression Pattern

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Stroke and Cerebral Ischemia

Psychiatric Disorders

Therapeutic Implications

Animal Models

Mef2a Knockout Mice

Transgenic Models

Research Directions

Overview

Background

References

See Also

External Links

Pathway Diagram